Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Drug Discovery Today|March 1, 2022
How nano-engineered delivery systems can help marketed and repurposed drugs in Alzheimer's disease treatment?Line Séguy, Anne-Claire Groo, Aurélie Malzert-FréonPharmaceutics|December 1, 2020
Design of Non-Haemolytic Nanoemulsions for Intravenous Administration of Hydrophobic APIsLine Séguy, Anne-Claire Groo, Didier Goux, et al.Journal of Experimental Orthopaedics|June 13, 2025
Growth differentiation factor 5 improves meniscal healing in a pilot study on ratsDavid Mazy, Nathaniel Léveillé, Line Séguy, et al.International Journal of Pharmaceutics|August 21, 2025
Peptide-grafted nanogels for sustained endothelin and bradykinin blockade in osteoarthritisSeng Manivong, Araceli Garcia-Ac, Louiza Mahrouche, et al.Pharmaceutics|October 23, 2021
Active Targeted Nanoemulsions for Repurposing of Tegaserod in Alzheimer's Disease TreatmentLine Séguy, Léna Guyon, Manon Maurel, et al.International Journal of Pharmaceutics|November 27, 2022
In vitro evaluation of NA1-115-7-loaded nanoemulsions, an MCL-1-specific inhibitor of natural origin, intended to treat B-cell lymphoproliferative disorders after oral administrationLine Séguy, Florian Daressy, Sophia Lahlil, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 21, 2022
NA1-115-7, from Zygogynum pancheri, is a new selective MCL-1 inhibitor inducing the apoptosis of hematological cancer cells but non-toxic to normal blood cells or cardiomyocytesFlorian Daressy, Line Séguy, Loëtitia Favre, et al.Advanced Materials (Deerfield Beach, Fla.)|March 29, 2024
Bioinspired Bottlebrush Polymers Effectively Alleviate Frictional Damage Both In Vitro and In VivoDuy Anh Pham, Chang-Sheng Wang, Line Séguy, et al.Communications Biology|February 1, 2025
Evidence from a mouse model supports repurposing an anti-asthmatic drug, bambuterol, against Alzheimer's disease by administration through an intranasal routeAnne-Claire Groo, Thomas Curel, Aurélie Malzert-Fréon, et al.International Journal of Pharmaceutics|July 15, 2026
Enhancing brain delivery of tegaserod for Alzheimer's disease: a pharmaceutical comparison of two nanocarrier-based strategiesLine Séguy, Léna Guyon, Sophie Corvaisier, et al.Pageof 1